title: Analysis of sleep disorders under pain using an optogenetic tool: possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons.
abstract: BACKGROUND
  Several etiological reports have shown that chronic pain significantly interferes with sleep. Inadequate sleep due to chronic pain may contribute to the stressful negative consequences of living with pain. However, the neurophysiological mechanism by which chronic pain affects sleep-arousal patterns is as yet unknown. Although serotonin (5-HT) was proposed to be responsible for sleep regulation, whether the activity of 5-HTergic neurons in the dorsal raphe nucleus (DRN) is affected by chronic pain has been studied only infrequently. On the other hand, the recent development of optogenetic tools has provided a valuable opportunity to regulate the activity in genetically targeted neural populations with high spatial and temporal precision. In the present study, we investigated whether chronic pain could induce sleep dysregulation while changing the activity of DRN-5-HTergic neurons. Furthermore, we sought to physiologically activate the DRN with channelrhodopsin-2 (ChR2) to identify a causal role for the DRN-5-HT system in promoting and maintaining wakefulness using optogenetics.
  
  
  RESULTS
  We produced a sciatic nerve ligation model by tying a tight ligature around approximately one-third to one-half the diameter of the sciatic nerve. In mice with nerve ligation, we confirmed an increase in wakefulness and a decrease in non-rapid eye movement (NREM) sleep as monitored by electroencephalogram (EEG). Microinjection of the retrograde tracer fluoro-gold (FG) into the prefrontal cortex (PFC) revealed several retrogradely labeled-cells in the DRN. The key finding of the present study was that the levels of 5-HT released in the PFC by the electrical stimulation of DRN neurons were significantly increased in mice with sciatic nerve ligation. Using optogenetic tools in mice, we found a causal relationship among DRN neuron firing, cortical activity and sleep-to-wake transitions. In particular, the activation of DRN-5-HTergic neurons produced a significant increase in wakefulness and a significant decrease in NREM sleep. The duration of NREM sleep episodes was significantly decreased during photostimulation in these mice.
  
  
  CONCLUSIONS
  These results suggest that neuropathic pain accelerates the activity of DRN-5-HTergic neurons. Although further loss-of-function experiments are required, we hypothesize that this activation in DRN neurons may, at least in part, correlate with sleep dysregulation under a neuropathic pain-like state.
authors.forename: Hisakatsu
authors.initials: H
authors.lastname: Ito
authors.forename: Makoto
authors.initials: M
authors.lastname: Yanase
authors.forename: Akira
authors.initials: A
authors.lastname: Yamashita
authors.forename: Chigusa
authors.initials: C
authors.lastname: Kitabatake
authors.forename: Asami
authors.initials: A
authors.lastname: Hamada
authors.forename: Yuki
authors.initials: Y
authors.lastname: Suhara
authors.forename: Michiko
authors.initials: M
authors.lastname: Narita
authors.forename: Daigo
authors.initials: D
authors.lastname: Ikegami
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Sakai
authors.affiliation: Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan. myama@med.u-toyama.ac.jp.
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Yamazaki
authors.forename: Minoru
authors.initials: M
authors.lastname: Narita
mesh_terms: D000818:Animals; D003956:Dialysis; D004558:Electric Stimulation; D004569:Electroencephalography; D006930:Hyperalgesia / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D008026:Ligation; D051379:Mice; D008845:Microinjections; D009437:Neuralgia / Q000150:complications* / Q000503:physiopathology; D062308:Optogenetics / Q000379:methods*; D017397:Prefrontal Cortex / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D011903:Raphe Nuclei / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D012584:Sciatic Nerve / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D059326:Serotonergic Neurons / Q000378:metabolism*; D012890:Sleep; D012893:Sleep Wake Disorders / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D013266:Stilbamidines / Q000378:metabolism; D019076:Transgenes; D014851:Wakefulness
chemical_list: C049774:2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; D013266:Stilbamidines